Brief: Aroa Biosurgery Says FY24 Product Revenue Guidance Maintained At NZ$72-75 Million
31/07/2023 02:41
July 31 (Reuters) - Aroa Biosurgery Ltd ARX.AX :
* FY24 PRODUCT REVENUE GUIDANCE MAINTAINED AT NZ$72-75
MILLION
* FY24 PRODUCT GROSS MARGIN GUIDANCE MAINTAINED AT 85%
* FY24 NORMALISED EBITDA PROFIT GUIDANCE MAINTAINED AT NZ$1
MILLION-NZ$2 MILLION
Source text for Eikon: ID:nASX8dRlyN
Further company coverage: ARX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million